"Chiesi drops COPD and asthma asset after Phase III miss" was originally created and published by Clinical Trials Arena, a ...
A single-inhaler triple therapy improved lung function in adults and adolescents with inadequately controlled asthma and was ...
Ambetter from WellCare of Kentucky, a product offered by a Centene Corporation (NYSE: CNC) company, a leading healthcare ...
and increased reliance on rescue inhalers, he said. Studies from AIIMS and Vallabhbhai Patel Chest Institute show a 15–25 % ...
Chronic obstructive pulmonary disease is a condition caused by damage to the lungs that results in breathing difficulties.
The latest investment brings the British pharma’s total investment at the site in Qingdao to $886 million. AstraZeneca ...
Firecracker smoke, pollen, and fungal spores are combining to worsen respiratory discomfort. Children under five and older ...
COPD emerged as an umbrella term for several respiratory diseases, including emphysema and chronic bronchitis, caused by lung damage. Because its effects are irreversible, early diagnosis and ...
Breathing wildfire smoke, even briefly, can change the bacteria and immune cells in your lungs, which may contribute to ...
Learn how to manage monsoon-related mould, fungal infections, and flood-borne diseases to stay healthy this season.
Chonnam National University Hospital and Hwasun Chonnam National University Hospital announced on November 5 that they both ...
Eli Lilly expanded its AI drug discovery pact with XtalPi to antibodies. Celltrion in-licensed two innovative autoimmune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results